Broadcom named strategic vendor for Walmart virtualization solutions
SCOTTSDALE, Ariz. - LifeStance Health (NASDAQ:LFST), a provider of outpatient mental health care services with a market capitalization of $2.14 billion and annual revenue of $1.32 billion, announced Friday the appointment of Sarah Personette to its board of directors, effective immediately.
William Miller, who serves as Wellsky Chairman and CEO, will step down from the board after five years of service, according to a company press release.
Personette brings over 20 years of experience in customer experience, media and technology. She currently serves as CEO of Puck, a journalist-owned media platform. Previously, she held the position of Chief Customer Officer at X (formerly Twitter), where she oversaw global revenue, customer relationships and business operations.
Her prior roles include Chief Operating Officer at Refinery29, Vice President of Global Business Marketing at Facebook, and senior positions at advertising agencies Universal McCann Worldwide and Starcom Mediavest Group.
"Sarah’s longstanding focus on understanding consumer behavior to improve the customer experience parallels our commitment to delivering patient-centered care," said Dave Bourdon, CEO of LifeStance Health.
Bourdon also acknowledged Miller’s contributions, stating, "He played an important role in advancing our organization’s mission during his tenure on the board."
Founded in 2017, LifeStance Health operates across 33 states with more than 550 centers, employing approximately 7,700 mental health professionals including psychiatrists, advanced practice nurses, psychologists and therapists.
In other recent news, LifeStance Health Group Inc. reported its earnings for the second quarter of 2025, showcasing a mixed financial performance. The company achieved an earnings per share (EPS) of -$0.01, which was better than the anticipated -$0.03. Revenue came in at $345 million, slightly exceeding the expected $345.05 million, and reflecting an 11% increase compared to the previous year. Despite these results, the stock experienced a decline in pre-market trading. There were no reports of mergers or acquisitions during this period. Analyst firms have not provided any recent upgrades or downgrades for LifeStance Health. These developments are part of the company’s recent financial disclosures.
This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.